An Immunohistochemical Study in Urothelial Carcinoma of HER2/neu in Iraqi Patients by Athraa Falah Alshimerry

Subjects: “…her2/neu…”
Get full text

PIK3CA mutations in breast cancer with low HER2 / neu expression by I. A. Pavlenko, P. E. Povilaitite, V. Yu. Kaciyaev, N. S. Makarevich, A. V. Petrov

“…The study was carried out on 32 breast cancer samples with a luminal HER2‑negative immunophenotype, which were divided into two groups – with low HER2 / neu expression (n = 15) and with a complete absence of HER2 / neu expression (n = 17). …”
Get full text

Prognostic value of immunohistochemical marker HER2/neu in patients resected for gastric cancer stage IIIA by O. M. Levyk

Subjects: “…immunohistochemical biomarker HER2/neu…”
Get full text

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry by Saiqa Nisar, Sukla Naskar, Saumitra Biswas

Subjects: Get full text

Expression of Human Epidermal Growth Factor Receptor (HER2/neu) and Proliferative Marker Ki-67 in Nonneoplastic, Preneoplastic, Neoplastic Lesions of Gallbladder and Its Association with Clinicopathological Parameters by Kiran Yadav, Deepti Arora, Seema Awasthi, Nikhil Chaudhary

Subjects: Get full text

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma by Axel Walch, Karin Bink, Peter Gais, Stefan Stangl, Peter Hutzler, Michaela Aubele, James Mueller, Heinz Höfler, Martin Werner

“…Amplifiction of the Her-2/neu gene is accompanied by overexpression of its cell surface receptor product, c‐erbB‐2 protein. …”
Get full text

Immunohistochemical Study of Ki-67 and HER2/neu and its Correlation with Clinicopathological Features in Surface Epithelial Tumors of the Ovary by Sameeksha Alva, Aravind Pallipady

Subjects: Get full text

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer by A. V. Avgustinovich, S. G. Afanasyev, L. V. Spirina, E. V. Kaygorodova, R. V. Ermolenko, E. N. Samtsov, I. G. Frolova, O. V. Cheremisina

Subjects: Get full text

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS by E. V. Kaigorodova, M. V. Bogatyuk, M. V. Zavyalova, N. A. Tarabanovskaya, E. I. Simolina, E. M. Slonimskaya, E. L. Choynzonov, V. M. Perelmuter

Subjects: Get full text

Concordance Between ER, PR, HER2 neu Receptors Before and After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer by Taha Heba F., Elfarargy Ola M., Salem Reham A., Mandour Doaa, Salem Amira A., Riad Mohamed

Subjects: Get full text

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice by Maria Laura De Angelis, Federica Francescangeli, Eleonora Aricò, Paola Verachi, Massimo Zucchetti, Cristina Matteo, Elena Petricci, Emanuela Pilozzi, Isabella Orienti, Alessandra Boe, Adriana Eramo, Rachele Rossi, Tiberio Corati, Daniele Macchia, Anna Maria Pacca, Ann Zeuner, Marta Baiocchi

“…For in vivo studies, we used HER2/neu transgenic mice (neuT) as a model of spontaneously metastatic BC. …”
Get full text

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO? by Yu. S. Shatova, V. V. Tokmakov, L. Yu. Vladimirova, L. N. Vaschenko

“…Choosing an optimal strategy for adjuvant chemotherapy (ACT) in postmenopausal women with primary operable luminal BC B subtype without overexpression of HER2/neu appears to be the most challenging.Objective: to evaluate treatment outcomes in postmenopausal women with primary operable luminal BC without overexpression of HER2/neu depending on the ACT used.Materials and methods. …”
Get full text

Immunohistochemical Expression of ROS1 in invasive ductal carcinoma of breast in association with hormonal receptor status and Her2Neu expression by Muhammad Umair, Ahmed Ahson Khan, Nighat Jamal, Akhter Ali Bajwa, Tabish Hassan, Muhammad Umair Khan

Get full text

Toxoplasma gondii destroys Her2/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach by Esra Atalay Şahar, Mert Döşkaya, Muhammet Karakavuk, Hüseyin Can, Aytül Gül, Adnan Yüksel Gürüz, Aysu Değirmenci Döşkaya, Levent Yeniay

Subjects: Get full text

A study of HER-2/neu expression and silver binding nucleolar organizer regions (Ag NORs) in perilesional normal salivary gland tissue by Essam Taher M.A. Gaballah

“…Keywords: Histogenesis, HER-2/neu expression, AgNORs, Salivary gland neoplasms…”
Get full text

Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer by V. Sekhri, N. Jain, S. Kapoor

Subjects: Get full text

The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu by Olga D. Bragina, Maria S. Larkina, Elena S. Stasyuk, Vladimir I. Chernov, Mekhman S. Yusubov, Victor S. Skuridin, Sergei M. Deyev, Roman V. Zel’chan, Michael A. Buldakov, Ekaterina V. Podrezova, M. V. Belousov

Subjects: Get full text

Assessing functional suitability of a lyophilized formulation containing designed ankyrin repeat proteins for radionuclide imaging of HER2/neu overexpression in malignant tumors by R. N. Varvashenya, A. A. Prach, E. V. Plotnikov, S. M. Deev, M. V. Belousov, M. S. Larkina, V. I. Chernov

Subjects: Get full text

Hubungan Overekspresi HER-2/neu dengan Status Reseptor Hormonal dan Grading Histopatologi pada Penderita Karsinoma Payudara di RS Onkologi Surabaya by JACOBUS OCTOVIANUS, SINDRAWATI, ARIO DJATMIKO

Subjects: Get full text

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor by V. V. Tokmakov, E. P. Ulianova, Yu. S. Shatova, A. B. Sagakyants, N. M. Mashchenko, I. A. Novikova, E. M. Nepomnyashchaya, O. G. Shulgina

“…Evaluation of the expression of E- and N-cadherins in tumor tissues in postmenopausal patients with primary operable luminal breast cancer (BC) without Her2/neu overexpression for inclusion in the panel of a comprehensive assessment of tumor biological parameters for the disease prognosis.Patients and methods. …”
Get full text